|
|
|
School
|
Status
|
Round
|
Year
|
GMAT
GRE
|
GPA
|
YOE
Years of Experiance
|
Post-MBA industry
|
Location
|
Date
|
|---|---|---|---|---|---|---|---|---|---|
| Full Time MBA |
Admitted, ($)
|
Round 2 | 2026 | 327 GRE | 3.6 | 5 | Consulting | United States |
01 Apr 2026 09:04 AM
|
| Full Time MBA |
Denied without Interview
|
Round 2 | 2026 | 320 GRE | 6 | Healthcare/Pharmaceuticals | United Kingdom |
29 Mar 2026 04:24 AM
|
|
| Full Time MBA |
Waitlisted with Interview
|
Round 2 | 2026 | 695 GMAT Focus | 3 | 8 | Technology | Korea, Republic of |
27 Mar 2026 04:55 PM
|
| Full Time MBA |
Admitted from WL
|
Round 1 | 2026 | 735 GMAT Focus | 0 | Consulting | India |
26 Mar 2026 07:08 PM
|
|
| Full Time MBA |
Waitlisted with Interview
|
Round 1 | 2026 | 3.6 | 8 | Technology | United States |
26 Mar 2026 04:40 PM
|
|
| Full Time MBA |
Denied without Interview
|
2026 | 675 GMAT Focus | 5 | Consulting |
26 Mar 2026 10:24 AM
|
|||
| Full Time MBA |
Admitted
|
Round 2 | 2026 | 645 GMAT Focus | 3.6 | 5 | Finance: Investment Banking | Azerbaijan |
26 Mar 2026 07:37 AM
|
| Full Time MBA |
Admitted from WL
|
Round 1 | 2026 | 685 GMAT Focus 705 GMAT Focus |
7.3 | 5 | Finance: Investment Banking | Brazil |
26 Mar 2026 07:37 AM
|
| Full Time MBA |
Waitlisted with Interview
|
Round 2 | 2026 | 675 GMAT Focus | 7.1 | 6 | Consulting | India |
26 Mar 2026 07:26 AM
|
| Full Time MBA |
Waitlisted with Interview
|
Round 2 | 2026 | 3.9 | 2 | Consulting | United States |
26 Mar 2026 07:11 AM
|
|
| Executive MBA (Chicago, London, & Hongkong) |
Admitted
|
Round 2 | 2026 | 161 EA | 3.6 | 15 | Healthcare/Pharmaceuticals | United States |
26 Mar 2026 06:31 AM
|
| Full Time MBA |
Matriculating
|
Round 1 | 2026 | 5 | Finance: Investment Banking | United States |
19 Mar 2026 11:01 AM
|
||
| Full Time MBA |
Denied without Interview
|
2026 | 715 GMAT Focus | 8.4 | 7 | Technology | India |
17 Mar 2026 07:09 PM
|
|
| Full Time MBA |
Waitlisted without Interview
|
2026 | 337 GRE | 8.5 | 5 | Consulting | India |
16 Mar 2026 03:48 PM
|
|
| Booth MiM |
Denied without Interview
|
2026 | 336 GRE | 2 | Healthcare/Pharmaceuticals | India |
13 Mar 2026 06:08 AM
|
||
| Booth MiM |
Denied without Interview
|
2026 | 318 GRE | 8 | 2 | Energy | India |
12 Mar 2026 10:27 AM
|
|
| Full Time MBA |
Interviewed
|
Round 2 | 2026 | 333 GRE | 8 | Finance: Investment Banking | India |
11 Mar 2026 10:26 PM
|
|
| Booth Scholars |
Deferred to Next Year
|
2028 | 3.5 | 0 | Consulting | India |
10 Mar 2026 08:17 PM
|
||
| Full Time MBA |
Interviewed
|
Round 2 | 2026 | 675 GMAT Focus 675 GMAT Focus 329 GRE |
7.7 | 7 | Technology | India |
04 Mar 2026 10:40 AM
|
| Full Time MBA |
Interviewed
|
Round 2 | 2026 | 655 GMAT Focus 164 EA |
3.4 | 5 | Technology | Korea, Republic of |
03 Mar 2026 11:17 PM
|